Showing results (1521-1530 of 3,569) with videos related to

Sort By:
Pageof 357
Journal of Thrombosis and Thrombolysis|December 29, 2012
Association analysis of USF1 gene polymorphisms and total unstable carotid plaque area in atherosclerotic stroke patientsRui-Min Wang, Zhi-Zhong Liu, Yan-Hua Gong, et al.
Journal of Thrombosis and Thrombolysis|May 31, 2012
Paradoxical thrombosis, part 2: anticoagulant and antiplatelet therapyGiuseppe Lippi, Emmanuel J Favaloro, Massimo Franchini
Journal of Thrombosis and Thrombolysis|May 31, 2012
PAR-1 antagonists: current state of evidenceSaurav Chatterjee, Abhishek Sharma, Debabrata Mukherjee
Journal of Thrombosis and Thrombolysis|August 15, 2013
Off-label thrombolysis versus full adherence to the current European Alteplase license: impact on early clinical outcomes after acute ischemic strokeManuel Cappellari, Giuseppe Moretto, Nicola Micheletti, et al.
Journal of Thrombosis and Thrombolysis|August 27, 2013
Efficacy and safety of tenecteplase in pulmonary embolismAnand N Shukla, Bhavesh Thakkar, Ashwal A Jayaram, et al.
Journal of Thrombosis and Thrombolysis|September 24, 2013
Cangrelor for patients undergoing percutaneous coronary intervention: evidence from a meta-analysis of randomized trialsPartha Sardar, Ramez Nairooz, Saurav Chatterjee, et al.
Journal of Thrombosis and Thrombolysis|June 4, 2013
Urokinase-coated chitosan nanoparticles for thrombolytic therapy: preparation and pharmacodynamics in vivoHai-jiang Jin, Hao Zhang, Min-li Sun, et al.
Journal of Thrombosis and Thrombolysis|June 5, 2013
Warfarin use and long-term outcomes in patients with acute myocardial infarction and atrial fibrillationJames A Nelson, John P Vavalle, Christopher H May, et al.
Journal of Thrombosis and Thrombolysis|May 17, 2013
The effect of CYP2C9, VKORC1 and CYP4F2 polymorphism and of clinical factors on warfarin dosage during initiation and long-term treatment after heart valve surgeryVacis Tatarunas, Vaiva Lesauskaite, Audrone Veikutiene, et al.
Pageof 357